0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2007;298(17):1977. doi:10.1001/jama.298.17.1977.
Text Size: A A A
Published online

TEZOSENTAN IN PATIENTS WITH ACUTE HEART FAILURE

Patients with heart failure have increased plasma concentrations of the vasoconstrictor peptide endothelin-1, which has been associated with worse clinical outcomes. In the Value of Endothelin Receptor Inhibition With Tezosentan in Acute Heart Failure Studies (VERITAS), 1448 patients with acute heart failure were randomly assigned to receive either tezosentan or placebo. Change in dyspnea over 24 hours and the incidence of death or worsening of heart failure at 7 days were assessed. McMurray and colleagues, writing for the study investigators, report that tezosentan offered no benefit vs placebo for these clinical outcomes.

CHANGING RELATIONSHIP OF OBESITY AND DISABILITY

Some evidence suggests that today's obese population is healthier than the obese population in the 1960s. To assess whether such health improvement is associated with a reduced risk of disability, Alley and ChangArticle analyzed self-reported functional limitations in mobility and the performance of 3 activities of daily living (ADLs) among participants aged 60 years and older in the National Health and Nutrition Examination Surveys for 1988-1994 and 1999-2004. The authors found that functional impairment among obese individuals increased 5.4% and ADL impairment did not change between 1988-1994 and 1999-2004. In contrast, among normal-weight individuals there was no change in functional impairment, and ADL limitations declined. In an editorial, Gregg and GuralnikArticle discuss the long-term effects of obesity on disability.

EXCESS CAUSE-SPECIFIC MORTALITY AND BMI

In a prior study, Flegal and colleagues found that compared with individuals of normal weight, those who were underweight or obese had significantly increased risks of all-cause mortality and that overweight individuals had a decreased risk. To further explore these associations, the authors analyzed national data on mortality and body mass index (BMI) for adults 25 years and older and calculated cause-specific excess deaths associated with underweight, overweight, and obesity. The authors report cause-specific excess deaths by BMI levels for cardiovascular disease, cancer, and all other causes in 2004.

PREVALENCE OF CHRONIC KIDNEY DISEASE IN THE US

To update the estimated prevalence of chronic kidney disease (CKD) in the United States, Coresh and colleagues analyzed data from the 1988-1994 and 1999-2004 National Health and Nutrition Examination Surveys and assessed the contributions of diabetes, hypertension, and obesity to changes in CKD prevalence. The authors report that between 1988-1994 and 1999-2004, the prevalence of CKD increased from 10% to 13%. This increase in prevalence was partly explained by the increasing prevalence of diabetes and hypertension among individuals 20 years and older.

CLINICIAN'S CORNER

Mr P, a 63-year-old man with multiple cardiovascular risk factors, has been poorly adherent to suggested medical regimens for more than 20 years. Bodenheimer discusses a 5-step process for the practice of evidence-based medicine and the responsibilities of physicians, health care systems, and patients to ensure the benefits of evidence-based medicine are realized.

A PIECE OF MY MIND

“We all use defense mechanisms to deal with pain, and mine was intellectualization.” From “Teddy.”

MEDICAL NEWS & PERSPECTIVES

Ongoing research to detect tumor-specific DNA in the blood may help improve diagnostic testing for cancer.

COMMENTARIES

Global strategies for tobacco control

New era of cardiovascular disease epidemiology

Monitoring improvement in patient safety

AUTHOR IN THE ROOM TELECONFERENCE

Join R. Monina Klevens, DDS, MPH, November 21 from 2 to 3 PM eastern time to discuss invasive methicillin-resistant Staphylococcus aureus infections. To register, go to http://www.ihi.org/AuthorintheRoom.

AUDIO COMMENTARY

Dr DeAngelis summarizes and comments on this week's issue. Go to http://jama.ama-assn.org/misc/audiocommentary.dtl

READERS RESPOND

How would you manage a 93-year-old man with advanced dementia and eating problems? Go to www.jama.com to read the case and submit your response. Your response may be selected for online publication with the article. Submission deadline is November 28.

JAMA PATIENT PAGE

For your patients: Information about assessing disability.

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.